Exploring improvements in bone strength in RA with Olumiant.

0 SAR
Checkout

Overview

Watch an animated video on the key outcomes of the BARE BONE study, showcasing improvements in bone strength in patients with RA when treated with Olumiant.

This Class for

  • Physician
  • Resident / Fellow

What I will learn?

  • Prof. Kleyer, author of the BARE BONE study, goes through the main outcomes of the study, highlighting the effects of Olumiant on bone properties in RA. As he goes through the data, visual animations support his voice over, bringing the data to life.
    The point of TL videos is also to let the authors present the outcomes of their studies. Animation videos are much more visual/graphical and do not feature a thought leader.




    Disclaimer

    This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
    (This information/content is intended to Health Care Providers only)

    For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
    24 /7 mobile : +966 567 868 843 working hours: +966 11 461 7800 , Ext: 1
    For Lilly product information: email: SAUDI_MEDINFOQUERIES@lilly.com
    For further information, please contact:
    Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: Saudi_Pharmacovigilance@lilly.com

    Please go to PDF Material for prescribing information


    PP-BA-SA-1192

Related Classes